Charles Schwab’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.26M Buy
598,630
+114,051
+24% +$430K ﹤0.01% 2626
2025
Q1
$2.2M Sell
484,579
-12,716
-3% -$57.6K ﹤0.01% 2581
2024
Q4
$3.52M Sell
497,295
-75,766
-13% -$536K ﹤0.01% 2502
2024
Q3
$4.66M Sell
573,061
-33,710
-6% -$274K ﹤0.01% 2408
2024
Q2
$3.88M Buy
606,771
+122,530
+25% +$783K ﹤0.01% 2459
2024
Q1
$3.65M Sell
484,241
-37,121
-7% -$280K ﹤0.01% 2400
2023
Q4
$4.83M Buy
521,362
+85,777
+20% +$794K ﹤0.01% 2327
2023
Q3
$4.41M Buy
435,585
+17,380
+4% +$176K ﹤0.01% 2312
2023
Q2
$5.23M Buy
418,205
+10,003
+2% +$125K ﹤0.01% 2224
2023
Q1
$4.76M Buy
408,202
+28
+0% +$327 ﹤0.01% 2221
2022
Q4
$4.34M Buy
408,174
+10,114
+3% +$108K ﹤0.01% 2292
2022
Q3
$3.86M Buy
398,060
+11,454
+3% +$111K ﹤0.01% 2355
2022
Q2
$5.6M Buy
386,606
+9,107
+2% +$132K ﹤0.01% 2140
2022
Q1
$9.87M Buy
377,499
+8,499
+2% +$222K ﹤0.01% 1961
2021
Q4
$14.6M Buy
369,000
+15,839
+4% +$628K ﹤0.01% 1793
2021
Q3
$17.7M Buy
353,161
+98,463
+39% +$4.92M 0.01% 1678
2021
Q2
$14.1M Buy
254,698
+27,499
+12% +$1.53M ﹤0.01% 1809
2021
Q1
$10.6M Buy
227,199
+12,692
+6% +$594K ﹤0.01% 1928
2020
Q4
$9.34M Buy
214,507
+12,024
+6% +$523K ﹤0.01% 1905
2020
Q3
$7.41M Buy
202,483
+97,024
+92% +$3.55M ﹤0.01% 1864
2020
Q2
$3.08M Buy
105,459
+34,240
+48% +$999K ﹤0.01% 2267
2020
Q1
$1.86M Buy
71,219
+23,792
+50% +$622K ﹤0.01% 2298
2019
Q4
$1.65M Buy
47,427
+1,201
+3% +$41.7K ﹤0.01% 2467
2019
Q3
$1.46M Buy
+46,226
New +$1.46M ﹤0.01% 2475